🇺🇸 FDA
Pipeline program

PRAX-628

PRAX-628-212

Phase 2 small_molecule active

Quick answer

PRAX-628 for Focal onset seizures or primary generalized tonic-clonic seizures is a Phase 2 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Focal onset seizures or primary generalized tonic-clonic seizures
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials